{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:19:40Z","timestamp":1774120780157,"version":"3.50.1"},"reference-count":6,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2006,6,28]],"date-time":"2006-06-28T00:00:00Z","timestamp":1151452800000},"content-version":"vor","delay-in-days":2126,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>A patient on disopyramide developed disopyramide toxicity when treated concurrently with azithromycin. Evidence of toxicity included an elevated serum disopyramide level and ventricular tachycardia requiring cardioversion. The azalide antibiotic presumably inhibited dealkylation of disopyramide to its major metabolite, mono\u2010N\u2010dealkyldisopyramide. Physicians should avoid using azithromycin in patients on disopvramide. If this drug combination is unavoidable, disopyramide levels must be closely monitored.<\/jats:p>","DOI":"10.1111\/j.1540-8159.2000.tb00976.x","type":"journal-article","created":{"date-parts":[[2006,6,28]],"date-time":"2006-06-28T15:22:05Z","timestamp":1151508125000},"page":"1433-1435","source":"Crossref","is-referenced-by-count":27,"title":["Potentially Fatal Interaction Between Azithromycin and Disopyramide"],"prefix":"10.1111","volume":"23","author":[{"given":"ERIC V.","family":"GRANOWITZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENNETH J.","family":"TABOR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMES B.","family":"KIRCHHOFFER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17299"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.6.1186"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90346-X"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/517061"},{"issue":"1","key":"e_1_2_1_6_2","first-page":"85","article-title":"The pharmacokinetics of Norpace","volume":"26","author":"Karim A","year":"1975","journal-title":"Angiology"},{"key":"e_1_2_1_7_2","first-page":"1425","article-title":"A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono\u2010N\u2010dealkylation metabolism of disopyramide with human liver micro\u2010somes","volume":"264","author":"Echizen H.","year":"1993","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2000.tb00976.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2000.tb00976.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:14:51Z","timestamp":1698599691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2000.tb00976.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1111\/j.1540-8159.2000.tb00976.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2000.tb00976.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}